Principal, Corporate Development, London

Isomorphic Labs is applying frontier AI to help unlock deeper scientific insights, faster breakthroughs, and life-changing medicines with an ambition to solve all disease. The future is coming. A future enabled and enriched by the incredible power of machine learning. A future in which diseases are curtailed or cured starting with better and faster drug discovery. Come and be part of an interdisciplinary team driving groundbreaking innovation and play a meaningful role in contributing towards us achieving our ambitious goals, while being a part of an inspiring and collaborative culture. The world we want tomorrow is the one we’re building today. It starts with the culture at this company. It starts with you. About Iso Isomorphic Labs (IsoLabs) was launched in 2021 to advance human health by building on and beyond the Nobel-winning AlphaFold system. Since then, our interdisciplinary team of drug discovery experts and machine learning specialists has built powerful new predictive and generative AI models that accelerate scientific discovery at digital speed. Our name comes from the belief that there is an underlying symmetry between biology and information science. By harnessing AI’s powerful capabilities, we can use it to model complex biological phenomena to help design novel molecules, anticipate how drugs will perform and develop innovative medicines to treat and cure some of the world’s most devastating diseases. We have built a world-leading drug design engine comprising AI models that are capable of working across multiple therapeutic areas and drug modalities. We are continually innovating on model architecture and developing cutting-edge capabilities to advance rational drug design. Every day, and with each new breakthrough, we’re getting closer to the promise of digital biology, and achieving our ambitious mission to one day solve all disease with the help of AI. Your impact As Principal, Corporate Development, you will serve as the team’s first full-time dedicated leader supporting Isomorphic Labs’ inorganic growth strategy and execution. Reporting to the VP of Corporate Strategy & Development, you will ensure our scientific and AI breakthroughs are paired with rigorous business case development, disciplined opportunity evaluation, and seamless transaction execution. Working at the centre of a highly collaborative cross-functional team, spanning R&D, Machine Learning, Business Development, Strategy & Operations, Legal, and Finance, you will own the end-to-end lifecycle of corporate transactions that expand our platform capabilities and long-term ecosystem reach. You will apply strong scientific and technical judgment to proactively identify and evaluate emerging opportunities, partner deeply with technical leaders to shape strategic recommendations, and lead high-impact acquisitions, minority investments, and strategic ventures from initial concept through close. What you will do • Market landscaping & scientific triage: Proactively map the external landscape across digital biology, biotechnology, and enabling technologies to identify opportunities that accelerate Isomorphic Labs’ long-term roadmap. Act as a rigorous first-pass technical and commercial filter - assessing scientific validity, technological differentiation, and strategic fit early so internal R&D teams focus on the highest-conviction opportunities • Business partnering & strategic case development: Build and maintain trusted relationships with business partners across Machine Learning, R&D, and Commercial to evaluate complex inorganic opportunities and crystalise clear, objective business cases. Synthesise scientific, technical, and financial considerations into structured executive recommendations (build vs. partner vs. invest/acquire) for th